Greg Scott has his own "China Bio" agenda, he's biased and a partner in a hedgefund that focuses on biopharma investing in China. He pushes his own interests in his articles.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.